The mission of the Eosinophilic Gastrointestinal Disorders (EGID) Program at Texas Children's Hospital is to provide personalized, high-quality patient care and increased access to cutting-edge research, innovative treatment advances and quality patient support groups for children and adolescents with EGID.
The Eosinophilic Gastrointestinal Disorders (EGID) Clinic provides a multidisciplinary approach to the evaluation and treatment of these patients through the collaborative efforts of gastroenterologists, allergists, dietitians, nurses, social workers, and psychologists. Texas Children's Hospital is one of a few centers that provides food patch testing as part of the diagnostic evaluation of patients with eosinophilic esophagitis.
The EGID program currently recruits individuals for a number of research and clinical studies through the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR). These include treatment studies with new therapeutic biologic medications, observational studies to determine the symptoms and outcomes of people with eosinophilic gastrointestinal disorders, and quality of life studies.